Search research articles
Contact Us
Filters
Showing results (51-60 of 160) with videos related to
Page
of 16
Sort By:
Endocrine
|
March 13, 2002
Potentiation and prolongation of the insulinotropic action of glucagon-like peptide 1 by methyl pyruvate or dimethyl ester of L-glutamic acid in a type 2 diabetes animal model
J Cancelas, M L Villanueva-Peñacarrillo, I Valverde, et al.
Acta Diabetologica
|
September 1, 1994
Impaired in vivo insulin secretion in response to non-glucidic secretagogues in adult rats after neonatal streptozotocin
D Vicent, M L Villanueva-Peñacarrillo, I Valverde, et al.
Diabetes
|
February 1, 1982
Mathematical modelling of cyclic AMP-Ca2+ interactions in pancreatic islets
W J Malaisse, I Valverde, A Owen, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
August 1, 1985
Plasma glucagon-immunoreactive components in early life in dogs
M Ghiglione, J M Pascual, A Rovira, et al.
Biochemistry International
|
April 1, 1989
Inhibition of proinsulin biosynthesis and conversion by a putative insulin mediator
J Camara, A Albor, J M Mato, et al.
Diabetes
|
September 1, 1970
Molecular size of extractable glucagon and glucagon-like immunoreactivity (GLI) in plasma
I Valverde, D Rigopoulou, J Marco, et al.
Diabete & Metabolisme
|
July 1, 1987
Plasma glucose, insulin, proinsulin, C-peptide and glucagon before and after a carbohydrate-rich meal in hyperthyroid patients
A Rovira, L Valdivielso, R Ortega, et al.
The Journal of Endocrinology
|
March 12, 2004
Cell signalling of glucagon-like peptide-1 action in rat skeletal muscle
A Acitores, N González, V Sancho, et al.
Diabetes Research (Edinburgh, Scotland)
|
February 1, 1989
Diazoxide-induced long-term hyperglycemia. II. Slackening of proinsulin conversion
I Valverde, C Alarcon, A Rovira, et al.
Diabetes
|
September 1, 1970
Characterization of glucagon-like immunoreactivity (GLI)
I Valverde, D Rigopoulou, J Marco, et al.
Page
of 16
Search research articles
Search
Showing results (51-60 of 160) with videos related to
Sort By:
Page
of 16
Endocrine
|
March 13, 2002
Potentiation and prolongation of the insulinotropic action of glucagon-like peptide 1 by methyl pyruvate or dimethyl ester of L-glutamic acid in a type 2 diabetes animal model
J Cancelas, M L Villanueva-Peñacarrillo, I Valverde, et al.
Acta Diabetologica
|
September 1, 1994
Impaired in vivo insulin secretion in response to non-glucidic secretagogues in adult rats after neonatal streptozotocin
D Vicent, M L Villanueva-Peñacarrillo, I Valverde, et al.
Diabetes
|
February 1, 1982
Mathematical modelling of cyclic AMP-Ca2+ interactions in pancreatic islets
W J Malaisse, I Valverde, A Owen, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
August 1, 1985
Plasma glucagon-immunoreactive components in early life in dogs
M Ghiglione, J M Pascual, A Rovira, et al.
Biochemistry International
|
April 1, 1989
Inhibition of proinsulin biosynthesis and conversion by a putative insulin mediator
J Camara, A Albor, J M Mato, et al.
Diabetes
|
September 1, 1970
Molecular size of extractable glucagon and glucagon-like immunoreactivity (GLI) in plasma
I Valverde, D Rigopoulou, J Marco, et al.
Diabete & Metabolisme
|
July 1, 1987
Plasma glucose, insulin, proinsulin, C-peptide and glucagon before and after a carbohydrate-rich meal in hyperthyroid patients
A Rovira, L Valdivielso, R Ortega, et al.
The Journal of Endocrinology
|
March 12, 2004
Cell signalling of glucagon-like peptide-1 action in rat skeletal muscle
A Acitores, N González, V Sancho, et al.
Diabetes Research (Edinburgh, Scotland)
|
February 1, 1989
Diazoxide-induced long-term hyperglycemia. II. Slackening of proinsulin conversion
I Valverde, C Alarcon, A Rovira, et al.
Diabetes
|
September 1, 1970
Characterization of glucagon-like immunoreactivity (GLI)
I Valverde, D Rigopoulou, J Marco, et al.
Page
of 16